INTERVIEWS

Returning guest, Dr. William Flood, Chief Medical Officer for Eviti at Nanthealth discusses the newly launched Eviti Connect for autoimmune diseases.  Used by over 6,900 oncology practices nationwide with its library of over 4,400 evidence-based treatment regimens, Eviti Connect is now able to serve as a go-to resource in the autoimmune space on top of its proven expertise in oncology.  The Eviti library now covers the most prevalent autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, plaque psoriasis and multiple sclerosis.  He talks about the company’s plans for this expansion and why they chose these two important areas of focus (cancer care and now autoimmune diseases).

Heart disease is the leading cause of death for women in the United States, yet only about half of women recognize that heart disease is their number one killer.  Returning guest, Dr. Suzanne Steinbaum, attending cardiologist in NYC, and founder and president of SRSHeart, discusses managing high cholesterol with a busy schedule, how statin therapy may be a critical part of achieving cholesterol goals and that there are several statins available but not all statins are the same.

Christoph Dankert discusses Carrum Health, the first digital health company directly connecting self-insured employers with the best providers in the nation, like Cleveland Clinic, John Hopkins and Mayo Clinic, to improve health outcomes, lower costs, and enhance the patient experience. He talks about the results of a recent peer-reviewed Rand Corp. study showing the vast difference in cost between fee-for-service and bundled payment surgery models, the emerging role of Centers of Excellence and key trends in value-based care.

Dr. Jenice Baker, Assistant Medical Director of the Emergency Department and Attending Physician at Our Lady of Lourdes Hospital in Camden NJ, discusses the “No Time to Wait” campaign    and educates viewers about deep vein thrombosis (DVT) and pulmonary embolism (PE) symptoms and why it’s critical for those experiencing symptoms that could be due to DVT or PE to consult a healthcare provider.

Heart failure (HF) accounts for nearly 2 hospitalizations every minute in the U.S.  Beth Davidson, a HF nurse practitioner in Nashville, TN, and President of the American Association of HF Nurses discusses HF, symptoms, the seriousness of HF hospitalization, and treatment and lifestyle tips that may help patients or a loved one manage the condition. She is joined by Kim , who at 32 was shocked to be diagnosed with HF.  She is now 53 and shares her story and how she is successfully managing her HF today. 

May is bladder cancer awareness month and Dr. Alicia Morgans, board-certified medical oncology physician at the Robert H. Lurie Comprehensive Cancer Center discusses the rise in bladder cancer cases, the most important questions for patients to ask their doctor, and explains why these tough conversations can be so important. She also talks about the new educational campaign “Let’s Target the Tough Stuff” to help people understand the warning signs and symptoms of the disease. 

Hospice patients with dementia are up to four times more likely to be disenrolled before death than patients without dementia (PWD). Additionally, PWD who are also racial minorities may receive lower quality of care while in hospice. Dr. Lauren Hunt, PhD, RN, FNP of UCSF, Department of Physiological Nursing, University of California San Francisco discusses these findings that were part of “Risk Factors for Disenrollment from Hospice in Persons with Dementia: A National Cohort Study”, that was presented at the 2021 American Geriatrics Society General Meeting.

Dr. Jonathan Edelman, MD, Vice President, Clinical Development at Seqirus discusses the Phase 3 clinical data presented at the 2021 Pediatric Academic Societies (PAS) virtual conference that supports the use of cell-based quadrivalent influenza vaccine (QIVc) in children 6 months to <4 years old.  He talks about the value of cell-based vaccine technology over traditional egg-based vaccines for pediatricians, their young patients and other patient populations, how cell-based influenza vaccines are designed to produce an exact match to viral strains annually selected by the WHO (building on evidence from 100 million QIVc doses distributed globally).  He also discusses the advantages of cell-based influenza technology over the standard manufacturing process in the event of a flu pandemic, being more scalable and offering faster production.

Oren Shuster, CEO of IM Cannabis, which offers government licensed cannabis products from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients discusses the international medical cannabis industry, their product portfolio, and their proprietary technologies that streamline and enhance production and can match certain strains with patients’ specific health conditions.  He also talks about the existing relationships with leading research institutions to ensure the high quality of its cannabis products.  The company is based in Israel and currently focuses on the European market.

Dawn Halkuff, Chief Commercial Officer of TherapeuticsMD discusses IMVEXXY® (estradiol vaginal inserts) and the new “Long May She Reign” Campaign aimed at women over 50. She is joined by Dr. Rebecca Brightman, Assistant Clinical Professor of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai who discusses painful sex due to menopause.